Skip to content

Relay Plus Thoracic Stent-Graft System 28-M334145302390URecalls & reported problems

Bolton Medical Inc. · Endovascular stent-graft system · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08435761002192), received between Sep 27, 2024 and Sep 27, 2024 — classified as 1 malfunction.

The most frequently reported specific device problem is “Difficult to Advance” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 1 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Difficult to Advance1
  • Failure to Advance1
  • Premature Activation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 27, 2024Premature Activation; Failure to Advance; Difficult to Advance; Premature Activation; Failure to Advance; Difficult to Advance

    "UNABLE TO ADVANCE THE INNER SHEATH: THE DELIVERY SYSTEM WAS ADVANCED INTO THE ARTERY AND THEN THE INNER SHEATH WAS ATTEMPTED TO BE ADVANCED OUT OF THE OUTER SHEATH. HOWEVER, THE INNER SHEATH WAS UNABLE TO PASS THROUGH THE UPPER PART OF THE CURVATURE OF THE AORTIC ARCH. PUSH-PULL MANIPULATION AND ROTATIONAL TORQUE WERE APPLIED, BUT THE INNER SHEATH WAS UNABLE TO BE PASSED THROUGH. THE PHYSICIAN CONSIDERED PERFORMING A PULL-THROUGH TECHNIQUE WITH THE DELIVERY SYSTEM KEPT IN THE AORTA, BUT DECIDED NOT TO PROCEED FURTHER AS IT WAS OBSERVED THAT THE INNER SHEATH HAD ALREADY BEEN PULLED DOWN SLIGHTLY, ALTHOUGH THE PROXIMAL STENT HAD NOT YET BEEN RELEASED. THE DELIVERY SYSTEM WAS ABLE TO BE SUCCESSFULLY REMOVED FROM THE PATIENT WITH THE AID OF THE LARGE ACCESS VESSEL, ALTHOUGH THE INNER SHEATH HAD ALREADY BEEN ADVANCED OUT OF THE OUTER SHEATH. OBSERVATION OF THE REMOVED DELIVERY SYSTEM REVEALED THAT THE INNER SHEATH HAD BEEN PULLED DOWN SLIGHTLY AND THE BARE STENT WAS EXPOSED, AS SPECULATED. AS THE DESCENDING AORTA WAS SIGNIFICANTLY TORTUOUS IN AN S-SHAPE AND THE UPPER PART OF THE CURVED AORTIC ARCH WAS QUITE NARROW, A PULL-THROUGH TECHNIQUE WAS PERFORMED TO ALLOW THE DELIVERY SYSTEM OF

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20327279 ↗

Other System, Endovascular Graft, Aortic Aneurysm Treatment devices

All System, Endovascular Graft, Aortic Aneurysm Treatment devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page